Rare diseases
Investigational molecules
Locations
240 East Grand Avenue Fl 2, 94080-4811, United States
ORIC Pharmaceuticals Inc. supports clinical research in advanced solid tumors with a focus on cancers driven by EGFR or HER2 alterations. The sponsor’s portfolio reflects interest in targeted cancer therapy across difficult-to-treat tumor types.
Research activity in this area is centered on molecularly defined oncology populations and treatment strategies for metastatic disease.
ORIC Pharmaceuticals Inc. runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
